AO
TMO icon

Advisor OS’s Thermo Fisher Scientific TMO Stock Holding History

Advisor OS’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$700K Sell
1,396
-165
-11% -$79.2K 0.05% 253
2026
Q1 		$767K Buy
1,561
+562
+56% +$305K 0.06% 219
2025
Q4 		$579K Buy
999
+124
+14% +$70.1K 0.05% 260
2025
Q3 		$425K Buy
875
+105
+14% +$48.9K 0.04% 290
2025
Q2 		$312K Sell
770
-1,172
-60% -$490K 0.03% 348
2025
Q1 		$967K Buy
1,942
+66
+4% +$35.7K 0.11% 129
2024
Q4 		$976K Sell
1,876
-1,083
-37% -$595K 0.11% 125
2024
Q3 		$1.83M Sell
2,959
-108
-4% -$63.9K 0.18% 99
2024
Q2 		$1.7M Sell
3,067
-153
-5% -$87.7K 0.19% 97
2024
Q1 		$1.87M Buy
3,220
+789
+32% +$443K 0.22% 86
2023
Q4 		$1.29M Sell
2,431
-535
-18% -$259K 0.17% 108
2023
Q3 		$1.5M Buy
2,966
+95
+3% +$50.6K 0.23% 82
2023
Q2 		$1.5M Buy
2,871
+30
+1% +$16.2K 0.25% 76
2023
Q1 		$1.64M Buy
2,841
+124
+5% +$69.9K 0.39% 59
2022
Q4 		$1.5M Buy
2,717
+212
+8% +$112K 0.4% 58
2022
Q3 		$1.27M Sell
2,505
-227
-8% -$127K 0.38% 55
2022
Q2 		$1.49M Buy
2,732
+147
+6% +$80.9K 0.43% 49
2022
Q1 		$1.53M Sell
2,585
-4,060
-61% -$2.33M 0.44% 51
2021
Q4 		$4.43M Buy
6,645
+315
+5% +$197K 0.9% 21
2021
Q3 		$3.62M Sell
6,330
-99
-2% -$54.3K 0.79% 27
2021
Q2 		$3.24M Sell
6,429
-227
-3% -$107K 0.67% 27
2021
Q1 		$3.04M Buy
6,656
+143
+2% +$68.3K 0.69% 28
2020
Q4 		$3.04M Buy
6,513
+3,288
+102% +$1.54M 0.81% 25
2020
Q3 		$1.42M Buy
3,225
+2,103
+187% +$869K 0.6% 23
2020
Q2 		$407K Buy
+1,122
New +$376K 0.24% 86

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Advisor OS's TMO Position: Q2 2026 in Review

Advisor OS reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $79.2K and leaving 1,396 shares worth $700K. The position accounts for 0.05% of the portfolio, ranked #253.

Advisor OS first reported a position in TMO in Q2 2020 and has held it in 25 quarters since. The position peaked at $4.43M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Advisor OS held 1,396 shares of Thermo Fisher Scientific worth $700K as of Q2 2026.
  • Advisor OS sold 165 Thermo Fisher Scientific shares in Q2 2026, an estimated $79.2K.
  • Thermo Fisher Scientific made up 0.05% of Advisor OS's portfolio in Q2 2026, its #253 holding.
  • Advisor OS first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 25 quarters since.
  • Advisor OS's Thermo Fisher Scientific position peaked at $4.43M in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Advisor OS's 13F filing for Q2 2026, filed 5 Aug 2026.